Stockreport

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes [Yahoo! Finance]

NewcelX Ltd. - Ordinary Shares  (NCEL) 
PDF ZURICH, Switzerland March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: NCEL), a clinical-stage company advancing stem-cell-derived therapies for Type 1 Dia [Read more]